Roche (RHHVF) Stock Price, News & Analysis

Company Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

Key Stats

• Today's Range: $312.27 to $320.01
• 50-Day Range: $286.95 to $351.50
• 52-Week Range: $247.20 to $354.19
• Volume: 364 shs
• Average Volume: 8,283 shs
• Market Capitalization: N/A
• P/E Ratio: 29.38
• Dividend Yield: 2.46%
• Price Target: N/A
• Consensus Rating: N/A

RHHVF Stock Analysis - Frequently Asked Questions

How have RHHVF shares performed this year?

Roche's stock was trading at $280.00 at the beginning of 2025. Since then, RHHVF shares have increased by 13.4% and is now trading at $317.6340.
View the best growth stocks for 2025 here.

How do I buy shares of Roche?

Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Ex-Dividend for 3/31 Dividend: 3/27/2025
• Record date for 3/31 Dividend: 3/28/2025
• Dividend Payable: 3/31/2025
• Today: 5/20/2025
• Next Earnings (Estimated): 7/24/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:RHHVF
• CIK: N/A
• Web: www.roche.com
• Phone: (161) 688-1111
• Fax: N/A
• Employees: 103,605
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 29.38
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A